Early decisions around trial design, endpoint selection, data strategy, and regulatory planning can influence not only execution, but also how well a program adapts as complexity increases.

For small and mid-sized biotechs operating under tight timelines and resource constraints, misalignment across clinical, data, and regulatory functions can create downstream challenges that are costly and difficult to resolve later in development. Global considerations across regions such as the US and EU can add further complexity.

This webinar will explore how more integrated approaches to clinical development can help reduce fragmentation, improve visibility across functions, and support key milestones such as First Patient In (FPI). Through a cross-functional discussion, attendees will gain practical insights into identifying early sources of risk and strengthening the foundation of their development strategy.